secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGIOS PHARMACEUTICALS, INC. (AGIO)
CIK:        0001439222
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001193125-22-009843
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Agios sets 2022 annual meeting for June 21; stockholder deadlines announced
---------------------------------------------------------------------------

- 2022 annual meeting to be held virtually on June 21, 2022.
- Deadline for Rule 14a-8 stockholder proposals for proxy inclusion is January 28, 2022.
- Other proposals or director nominations must be submitted between January 20 and February 19, 2022.
- Meeting date is more than 30 days after 2021 annual meeting, triggering adjusted deadline rules.
- Proposals must comply with applicable laws and company bylaws.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/0001193125-22-009843-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439222/000119312522009843/d295722d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-009843

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer